In this Innovation Spotlight, Dan Levangie, president and chief executive officer of CereVasc, discusses a new treatment strategy for NPH using an endovascularly implantable CSF shunt that minimizes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback